Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma

Clinical trial NCT00453102 · COMPLETED

Trial details

NCT number: NCT00453102
Sponsor: University of Miami
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Marginal Zone Lymphoma

Start date: 2006-02-01
Primary completion: 2015-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.